Výpis publikací

NĚMEC, Pavel, Zuzana ZEMANOVÁ, Kyra MICHALOVÁ, Jana TAJTLOVÁ, Henrieta GREŠLIKOVÁ, Hana FILKOVÁ, Romana ZAORALOVÁ, Ivan ŠPIČKA, Evžen GREGORA, Dana KRÁLOVÁ, Renata KUPSKÁ, Marta KREJČÍ, Luděk POUR, Lenka ZAHRADOVÁ, Viera SANDECKÁ, Zdeněk ADAM, Petr KUGLÍK a Roman HÁJEK. Gain/amplification of 1q21 is the most powerful genetic prognostic factor for patients treated by autologous stem cell transplantation. In Haematologica/The Hematology Journal. 2008. ISSN 0390-6078.

GREŠLIKOVÁ, Henrieta, Petr KUGLÍK, Hana FILKOVÁ, Alexandra OLTOVÁ, Zdeněk ADAM, Andrea KŘIVANOVÁ, Luděk POUR, Jana SMEJKALOVÁ, Marta KREJČÍ a Roman HÁJEK. CORRELATION BETWEEN CHROMOSOMAL ABERRATIONS AND STANDARD PROGNOSTIC FACTORS IN PATIENTS WITH MULTIPLE MYELOMA UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANTATION. In Blood reviews. Volume 21, Supplement 1. Edinburgh: Churchill Livingstone, 2007, s. 85-85. ISSN 0268-960X.

NĚMEC, Pavel, Henrieta GREŠLIKOVÁ, Petr KUGLÍK, Hana FILKOVÁ, Romana ZAORALOVÁ, Vladimíra VRANOVÁ, Jana SMEJKALOVÁ, Petra VIDLÁKOVÁ, Alexandra OLTOVÁ a Roman HÁJEK. Newly Diagnosed Multiple Myeloma Patients with 1q21 Amplification Treated by Autologous Stem Cell Transplantation Have Shorter Progression-Free Survival Interval. In Blood 2007, Vol.110(11) Part 2. Washington DC, USA: American Society of Hematology (ASH), 2007, s. 263B-263B, 1 s. ISSN 0006-4971.